Rabies Vaccine, Human I.P.
Generic Name:
Rabies Vaccine, Human I.P.
(Purified Inactivated, Lyophilized Rabies Vaccine, Prepared in vero cells)
Description:
The Pitman-Moore strain of the rabies virus, produced in Vero cells, is used to make the lyophilized, inactivated rabies vaccine. One dosage of the rabies vaccination for humans contains 2.5 IU of rabies antigen. As instructed on the label, the freeze-dried vaccine must be reconstituted right before use to produce a clear or faintly opalescent solution. The vaccination complies with WHO standards.
​
Composition:
After reconstitution, 1 vial contains.
​
Pharmaceutical Form:
PowdeLyophilized powder to be reconstituted for Injection.
Method of Administration:
The intramuscular approach and the intradermal route can both be used to give this vaccine (single dose for children and adults 0.1 ml per site in the upper arm).
Dosage:
0.5ml per dose
​
Presentation:
Single Dose Vial with Diluent
Possible Side Effects:
Pain, erythema, edoema, pruritus, and induration at the injection site are among the potential side effects. Fever, chills, disorientation, headaches, muscular aches, joint problems, and upset stomach are some other side effects.
Contraindications:
People who are known to be hypersensitive to any of the ingredients shouldn't receive it or receive it more than once.
​
Shelf Life:
36 months
Storage:
The reconstituted vaccine and the diluent should be stored at +2°C and +8°C and must be used within six hours of reconstitution. Shake firmly before using. Avoid freezing.